Performance of Tuberculin Skin Test Compared to QFT-IT to Detect Latent TB Among High-risk Contacts in Mexico

Archives of Medical Research

Volumn 44, Issue 3, 2013, Pages 242-248

  Serrano Escobedo, Carmen Judith ^a   Enciso Moreno, José Antonio ^a   Monárrez Espino, Joel ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

LTBI diagnosis; QFT IT assay; Tuberculin test

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; IMMUNODETECTION; INTERVIEW; KAPPA STATISTICS; LATENT TUBERCULOSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MEXICO; QUANTIFERON TB GOLD IN TUBE ASSAY; TUBERCULIN TEST;

ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HUMANS; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MEXICO; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 84876824618     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.02.004     Document Type: Article

References (39)

1. Morrison J., Pai M., Hopewell P.C. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:359-368.
2. Marks S.M., Taylor Z., Qualls N.L., et al. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000, 162:2033-2038.
3. Reichler M.R., Reves R., Bur S., et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002, 287:991-995.
4. Radhakrishna S., Frieden T.R., Subramani R., et al. Additional risk of developing TB for household members with a TB case at home at intake: a 15-year study. Int J Tuberc Lung Dis 2007, 11:282-288.
5. Fox G.J., Barry S.E., Britton W.J., et al. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2012, 41:140-156.
6. Prevention and control of tuberculosis in U.S. communities with at-risk minority populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 1992, 41:1-11.
7. Mack U., Migliori G.B., Sester M., et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009, 33:956-973.
8. Dye C., Garnett G.P., Sleeman K., et al. Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy. Lancet 1998, 352:1886-1891.
9. Pai M. Alternatives to the tuberculin skin test: interferon-gamma assays in the diagnosis of mycobacterium tuberculosis infection. Indian J Med Microbiol 2005, 23:151-158.
10. Harada N., Nakajima Y., Higuchi K., et al. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol 2006, 27:442-448.
11. Andersen P., Munk M.E., Pollock J.M., et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000, 356:1099-1104.
12. Pai M., Riley L.W., Colford J.M. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004, 4:761-776.
13. Arend S.M., Thijsen S.F., Leyten E.M., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175:618-627.
14. Diel R., Loddenkemper R., Meywald-Walter K., et al. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009, 135:1010-1018.
15. Mazurek G.H., Jereb J., Lobue P., et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005, 54:49-55.
16. Garfein R.S., Burgos J.L., Rodriquez-Lainz A., et al. Latent tuberculosis infection in a migrant agricultural community in Baja California, Mexico. J Immigr Minor Health 2011, 13:940-947.
17. Garfein R.S., Lozada R., Liu L., et al. High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico. Int J Tuberc Lung Dis 2009, 13:626-632.
18. Gonzalez-Salazar F., Vargas-Villarreal J., Garcialuna-Martinez F.J., et al. Snapshot of Quantiferon TB gold testing in Northern Mexico. Tuberculosis (Edinb) 2011, 91(suppl 1):S34-S37.
19. Taylor Z., Nolan C.M., Blumberg H.M. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep 2005, 54:1-81.
20. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000, 49:1-51.
21. Rangel-Frausto M.S., Ponce-De-Leon-Rosales S., Martinez-Abaroa C., et al. Tuberculosis and tuberculin quality: best intentions, misleading results. Infect Control Hosp Epidemiol 2001, 22:481-484.
22. Sgountzos V., Simopoulou S., Kretsou S., et al. Comparative study of RT23 and Merieux tuberculin tested among healthy volunteers. Int J Tuberc Lung Dis 2009, 13:312-316.
23. Dominguez J., Ruiz-Manzano J., De Souza-Galvao M., et al. Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 2008, 15:168-171.
24. Joos T.J., Miller W.C., Murdoch D.M. Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis 2006, 10:883-891.
25. Mandalakas A.M., Detjen A.K., Hesseling A.C., et al. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011, 15:1018-1032.
26. Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries. Policy Statement 2011, World Health Organization, WHO, Geneva, Switzerland, Online document available at the following link. http://whqlibdoc.who.int/publications/2011/9789241502672_eng.pdf.
27. Doberne D., Gaur R.L., Banaei N. Preanalytical delay reduces sensitivity of QuantiFERON-TB gold in-tube assay for detection of latent tuberculosis infection. J Clin Microbiol 2011, 49:3061-3064.
28. Shanaube K., De Haas P., Schaap A., et al. Intra-assay reliability and robustness of QuantiFERON(R)-TB Gold In-Tube test in Zambia. Int J Tuberc Lung Dis 2010, 14:828-833.
29. Fukui M., Shimakawa K., Itotani R., et al. Relationship between time taken from collection of blood to incubation and measurement in whole-blood interferon gamma assay for diagnosis of Mycobacterium tuberculosis infection. Kansenshogaku Zasshi 2007, 81:421-425.
30. Weinfurter P., Blumberg H.M., Goldbaum G., et al. Predictors of discordant tuberculin skin test and QuantiFERON(R)-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 2011, 15:1056-1061.
31. Nienhaus A., Schablon A., Diel R. Interferon-gamma release assay for the diagnosis of latent TB infection-analysis of discordant results, when compared to the tuberculin skin test. PLoS One 2008, 3:e2665.
32. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005, 54:1-47.
33. Larsen N.M., Biddle C.L., Sotir M.J., et al. Risk of tuberculin skin test conversion among health care workers: occupational versus community exposure and infection. Clin Infect Dis 2002, 35:796-801.
34. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159:15-21.
35. Aissa K., Madhi F., Ronsin N., et al. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am J Respir Crit Care Med 2008, 177:1041-1047.
36. Damaso B.D.R., Menacho L., Loza C. Reactividad de la prueba de tuberculina en contactos intradomiciliarios de pacientes con tuberculosis en Huanuco, Peru. Rev Peru Med Exp Salud Publica 2009, 26:449-454.
37. Goris-Pereiras A., Fernandez-Villar A., Choucino-Garrido N., et al. [Factors predicting new tuberculosis infections and tuberculin conversions in a contact tracing system]. Enferm Clin 2008, 18:183-189.
38. Metcalfe J.Z., Everett C.K., Steingart K.R., et al. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J Infect Dis 2011, 204(suppl 4):S1120-S1129.
39. Rangaka M.X., Wilkinson K.A., Glynn J.R., et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:45-55.